A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study

Michael A. Gold, William E. Brady, Heather A. Lankes, Peter G. Rose, Joseph L. Kelley, Koen De Geest, Marta A. Crispens, Kimberly E. Resnick, Stephen B. Howell

Research output: Contribution to journalArticlepeer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II study of a urokinase-derived peptide (A6) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube, or primary peritoneal carcinoma: A Gynecologic Oncology Group study'. Together they form a unique fingerprint.

Medicine & Life Sciences